Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05735743 · ClinicalTrials.gov registry record · NA
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
A NA study of End Stage Renal Disease on Dialysis, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 6
- Study locations
NCT05735743: Active NA study of End Stage Renal Disease on Dialysis, sponsored by Vanderbilt University Medical Center.
NCT05735743 is a NA study of End Stage Renal Disease on Dialysis that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 176 participants, above the 58-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (203% higher). The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05735743, a NA study of End Stage Renal Disease on Dialysis, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 6
- Study locations
Study Summary
MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).
Primary Outcome
Abstraction of dialysis treatment adherence data from the dialysis units' records which includes data on every treatment that occurred or should have occurred within the time frame. Records will reflect dialysis treatments which were completed, shortened, missed or did not occur due to hospitalizations, ER visits or travel. A shortened session is defined as a session that is shortened by 15 minutes or more (y/n, repeated measure).
Conditions Studied
Interventions
- BEHAVIORAL Motivational interviewing
Study Locations (6)
Pennsylvania
- DaVita Philadelphia PMC Dialysis - Philadelphia
- DaVita University City Dialysis - Philadelphia
- Buttonwood DaVita Dialysis 449 N Broad St, - Philadelphia, PA 19123
Tennessee
- Vanderbilt Dialysis Clinic - Nashville
- Dialysis Clinic, Inc. - Nashville
- Vanderbilt Dialysis Clinic East - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2023-10-09 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
What the registry record for NCT05735743 still lists
NCT05735743 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, above the 58-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (203% higher).
The record links to 1 condition, with End Stage Renal Disease on Dialysis appearing as the primary indexed condition, and to 1 intervention - of which Motivational interviewing is the first listed.
NCT05735743 lists 6 locations in 2 states (Pennsylvania, Tennessee).
Frequently Asked Questions
What is clinical trial NCT05735743 about?
NCT05735743 is a clinical study titled "MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence". MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical t...
What is the current status of trial NCT05735743?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2023-10-09. Estimated completion is 2027-11-01.
What conditions does trial NCT05735743 study?
This clinical trial studies the following conditions: End Stage Renal Disease on Dialysis.
What interventions are being tested in trial NCT05735743?
The interventions under investigation include: Motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05735743?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05735743 being conducted?
This trial has 6 study locations across Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease on Dialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05735743's enrollment target sits among peer trials
176 2nd of 9 the highest of 9 other End Stage Renal Disease on Dialysis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease on Dialysis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
RECRUITING · NA
-
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
RECRUITING · NA
-
The Home Blood Pressure (BP) Trial
ACTIVE NOT RECRUITING · NA
-
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
COMPLETED · NA
-
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
COMPLETED · NA
-
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI